The invention relates to novel polycyclic macrolactones, which can be produced in particular by a representative of the bacteria genus Verrucosispora. Said substances are preferably characterised by their pharmacological action and exhibit in particular an antibiotic action. Preferably, said antibiotic action is active against gram-positive bacteria